Bio X Cell InVivoSIM anti-human PD-1 (Tislelizumab biosimilar) - research-grade human IgG4 antibody for PD-1 blockade

Supplier:  Bio X Cell SIM0038R1MG

InVivoSIM anti-human PD-1 (Tislelizumab biosimilar) is a research-use-only, non-therapeutic monoclonal antibody that reproduces the variable regions of the therapeutic antibody. It is purified from cell culture supernatant in an animal-free facility and formulated in PBS (pH 7.0) without stabilizers or preservatives. The antibody is quality-tested for purity, aggregation, endotoxin, and sterility and is suitable for PD-1/PD-L blockade, functional assays, and ELISA.

• Research use only, non-therapeutic biosimilar.
• Human IgG4, κ isotype.
• Purity ≥95% determined by SDS-PAGE.
• Aggregation <5% determined by SEC.
• Endotoxin ≤0.5 EU/mg (≤0.0005 EU/μg).
• Sterile filtered through 0.2 μm.
• Formulated in PBS, pH 7.0, with no stabilizers or preservatives.
• Store at 4°C; do not freeze.
• Intended for PD-1/PD-L blocking, functional assays, and ELISA.

Catalog No. NC3865251